ES497066A0 - Un procedimiento para la preparacion de 1-oxo-1h-tiazolo-( 3-2-a) pirimidina. - Google Patents

Un procedimiento para la preparacion de 1-oxo-1h-tiazolo-( 3-2-a) pirimidina.

Info

Publication number
ES497066A0
ES497066A0 ES497066A ES497066A ES497066A0 ES 497066 A0 ES497066 A0 ES 497066A0 ES 497066 A ES497066 A ES 497066A ES 497066 A ES497066 A ES 497066A ES 497066 A0 ES497066 A0 ES 497066A0
Authority
ES
Spain
Prior art keywords
tiazolo
pirimidine
oxo
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES497066A
Other languages
English (en)
Spanish (es)
Other versions
ES8203363A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES8203363A1 publication Critical patent/ES8203363A1/es
Publication of ES497066A0 publication Critical patent/ES497066A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ES497066A 1979-11-23 1980-11-21 Un procedimiento para la preparacion de 1-oxo-1h-tiazolo-( 3-2-a) pirimidina. Granted ES497066A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9663179A 1979-11-23 1979-11-23

Publications (2)

Publication Number Publication Date
ES8203363A1 ES8203363A1 (es) 1982-04-01
ES497066A0 true ES497066A0 (es) 1982-04-01

Family

ID=22258306

Family Applications (1)

Application Number Title Priority Date Filing Date
ES497066A Granted ES497066A0 (es) 1979-11-23 1980-11-21 Un procedimiento para la preparacion de 1-oxo-1h-tiazolo-( 3-2-a) pirimidina.

Country Status (35)

Country Link
JP (1) JPS5687586A (sv)
KR (1) KR830004322A (sv)
AR (2) AR228859A1 (sv)
AT (1) AT380883B (sv)
AU (1) AU520995B2 (sv)
BE (1) BE886319A (sv)
CA (1) CA1143731A (sv)
CH (1) CH649299A5 (sv)
CS (1) CS241476B2 (sv)
DD (1) DD154608A5 (sv)
DE (2) DE3050491C2 (sv)
DK (1) DK151811C (sv)
EG (1) EG14929A (sv)
ES (1) ES497066A0 (sv)
FI (1) FI67706C (sv)
FR (1) FR2470132A1 (sv)
GB (1) GB2063862B (sv)
GR (1) GR72132B (sv)
GT (1) GT198066458A (sv)
HU (1) HU179091B (sv)
IE (1) IE50404B1 (sv)
IL (1) IL61535A (sv)
IN (1) IN154926B (sv)
IT (1) IT1209373B (sv)
LU (1) LU82950A1 (sv)
NL (1) NL182565C (sv)
NO (1) NO803521L (sv)
NZ (1) NZ195596A (sv)
PH (1) PH16666A (sv)
PL (1) PL132354B1 (sv)
PT (1) PT72090B (sv)
SE (1) SE448732B (sv)
SU (1) SU1042620A3 (sv)
YU (1) YU41953B (sv)
ZA (1) ZA807293B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8300728D0 (en) * 1983-01-12 1983-02-16 Erba Farmitalia Substituted carboxy-thiazolo / 3 2 - a / pyrimidine derivatives
US4457932A (en) * 1983-07-22 1984-07-03 Bristol-Myers Company Anti-ulcer agents
GB8422916D0 (en) * 1984-09-11 1984-10-17 May & Baker Ltd Compositions of matter
JP2690742B2 (ja) * 1987-03-30 1997-12-17 第一製薬株式会社 複素環アミン誘導体
NZ228447A (en) * 1988-03-28 1990-08-28 Janssen Pharmaceutica Nv Cosmetic or pharmaceutical composition possessing serotonin antogonistic activity
TWI500623B (zh) * 2009-10-13 2015-09-21 Torrent Pharmaceuticals Ltd 新穎稠合噻唑及噁唑嘧啶酮

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1331059A (en) 1971-04-19 1973-09-19 Lilly Industries Ltd Pyrimidotriazinone compounds
US4041163A (en) * 1976-03-29 1977-08-09 Pfizer Inc. N-(5-Tetrazolyl)-4-oxo-4H-pyrimido(2,1-b)benzothiazole-3-carboxamide antiallergy agents
DE2810863A1 (de) * 1978-03-13 1979-09-27 Boehringer Mannheim Gmbh 1-oxo-1h-pyrimido eckige klammer auf 6,1-b eckige klammer zu benzthiazol-derivate und verfahren zu ihrer herstellung
US4223031A (en) * 1978-05-05 1980-09-16 Mead Johnson & Company Azolopyrimidinones

Also Published As

Publication number Publication date
LU82950A1 (fr) 1981-06-04
PL132354B1 (en) 1985-02-28
NO803521L (no) 1981-05-25
NL182565C (nl) 1988-04-05
NZ195596A (en) 1984-05-31
FI67706C (fi) 1985-05-10
IL61535A (en) 1984-06-29
GB2063862B (en) 1983-06-22
ES8203363A1 (es) 1982-04-01
PH16666A (en) 1983-12-13
CS241476B2 (en) 1986-03-13
JPS617432B2 (sv) 1986-03-06
SU1042620A3 (ru) 1983-09-15
KR830004322A (ko) 1983-07-09
CH649299A5 (fr) 1985-05-15
AR231296A1 (es) 1984-10-31
PL228008A1 (sv) 1981-12-11
DE3050491C2 (de) 1985-10-10
IN154926B (sv) 1984-12-22
DK151811B (da) 1988-01-04
AT380883B (de) 1986-07-25
IL61535A0 (en) 1980-12-31
SE8008189L (sv) 1981-05-24
DE3043979C2 (de) 1986-08-21
YU41953B (en) 1988-02-29
AU520995B2 (en) 1982-03-11
PT72090A (en) 1980-12-01
GB2063862A (en) 1981-06-10
JPS5687586A (en) 1981-07-16
FI803628L (fi) 1981-05-24
CS782080A2 (en) 1985-06-13
CA1143731A (en) 1983-03-29
DK413180A (da) 1981-05-24
AU6459580A (en) 1981-05-28
GR72132B (sv) 1983-09-19
FI67706B (fi) 1985-01-31
PT72090B (en) 1981-09-29
AR228859A1 (es) 1983-04-29
ATA570780A (de) 1985-12-15
DK151811C (da) 1988-06-06
DE3043979A1 (de) 1981-09-03
SE448732B (sv) 1987-03-16
NL8006362A (nl) 1981-06-16
GT198066458A (es) 1982-05-15
IE802418L (en) 1981-05-23
YU295080A (en) 1983-06-30
ZA807293B (en) 1981-12-30
DD154608A5 (de) 1982-04-07
NL182565B (nl) 1987-11-02
HU179091B (en) 1982-08-28
IE50404B1 (en) 1986-04-16
IT1209373B (it) 1989-07-16
FR2470132A1 (fr) 1981-05-29
FR2470132B1 (sv) 1983-07-29
EG14929A (en) 1989-01-30
IT8026176A0 (it) 1980-11-21
BE886319A (fr) 1981-05-25

Similar Documents

Publication Publication Date Title
ES491534A0 (es) Un procedimiento para la preparacion de nuevos bis-esteres de metanodiol.
ES486786A0 (es) Un procedimiento para la preparacion de carboxialquil-dipep-tidos.
ES497304A0 (es) Un procedimiento para la preparacion de nuevos derivados de diarilamino-fluorano.
ES507041A0 (es) Un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina.
ES496586A0 (es) Un procedimiento para la preparacion de un derivado enzimatico.
ES494974A0 (es) Un procedimiento para la preparacion de un copolimero.
ES493525A0 (es) Un procedimiento para la preparacion de sulfonamidas.
ES491762A0 (es) Un procedimiento para la preparacion de sulfonamidas.
ES486782A0 (es) Un procedimiento para la preparacion de derivados de imida- zol.
ES479988A0 (es) Un procedimiento para la preparacion de nuevos derivados - hete rociclicos.
ES487843A0 (es) Un procedimiento para la preparacion de derivados de imida- zol.
ES477509A0 (es) Un procedimiento para la preparacion de derivados de fenil- piperacina.
ES494131A0 (es) Un procedimiento para la preparacion de diariltiofenos.
ES488886A0 (es) Un procedimiento para la preparacion de derivados acidos penemcarboxilicos.
ES491944A0 (es) Un procedimiento para la preparacion de tienamicinas.
ES495586A0 (es) Un procedimiento para la preparacion de derivados de oxazo- lidona- o tiazolidona.
ES488825A0 (es) Un procedimiento para la preparacion de nuevas sulfonamidas.
ES489149A0 (es) Un procedimiento para la preparacion de confituras congela- das.
ES495163A0 (es) Un procedimiento para la preparacion de derivados de carboestirilo.
ES491835A0 (es) Un procedimiento para la preparacion de mono-y-di-esteres desacarosa.
ES490722A0 (es) Un procedimiento para la preparacion de nuevos derivados de piridazina.
ES490211A0 (es) Un procedimiento para la preparacion de fenetanolaminas
ES507997A0 (es) Un procedimiento para la preparacion de nuevos derivados de la quinoleina.
ES491531A0 (es) Un procedimiento para la preparacion de sulfamidas.
ES497366A0 (es) Un procedimiento para la preparacion de nuevos compuestos de mercaptoorganosiloxano.